I
n this issue of JACC: Heart Failure, Arzt et al. (1) describe the prevalence of sleep-disordered breathing (SDB) in a registry of more than 6,800 patients with chronic stable systolic heart failure (HF) (heart failure with reduced ejection fraction
[HFREF]) in Germany. Breathing is moderately or severely abnormal during sleep (apnea-hypopnea index $15) in almost one-half of such patients. Importantly, the patients are less selected than in previous reports, being recruited from a wide variety of cardiology practices, and were treated to current guidelines-with high usage of angiotensinconverting enzyme inhibitors or angiotensin receptor blockers, beta-blockers, and aldosterone antagonists.
Which patients appear to be at highest risk of developing SDB? They report independent effects of increasing age, being male (almost twice the risk of females), and increased body mass index. The risk is 19% higher in those with atrial fibrillation, and goes up by 10% for every 5% drop in left ventricular ejection fraction. If we are screening for SDB (which is straightforward to do with modern technology), we know where to look hardest. It will be interesting to see whether these risk factors are the same for both obstructive (OSA) and central (CSA) sleep apnea, and whether both phenotypes are independently associated with mortality, in future reports from this registry. he has received research funding from ResMed; and he has received consultancy fees from ResMed, Respicardia, and Sorin. Cowie F E B R U A R Y 2 0 1 6 : 1 2 6 -8
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